Targeting the vascular endothelial growth factor in hematologic malignancies.
about
Knockdown of VEGFR2 inhibits proliferation and induces apoptosis in hemangioma-derived endothelial cells.Establishment and characterization of a novel VEGF-producing HHV-8-unrelated PEL-like lymphoma cell line, OGU1.Effects of a novel cyclic RGD peptidomimetic on cell proliferation, migration and angiogenic activity in human endothelial cellsVascular endothelial growth factor: the salt in the Hodgkin cytokine stew?Bone marrow microvessel density and plasma angiogenic factors in myeloproliferative neoplasms: clinicopathological and molecular correlations.Raised VEGF: High sensitivity and specificity in the diagnosis of POEMS syndrome
P2860
Targeting the vascular endothelial growth factor in hematologic malignancies.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Targeting the vascular endothelial growth factor in hematologic malignancies.
@en
type
label
Targeting the vascular endothelial growth factor in hematologic malignancies.
@en
prefLabel
Targeting the vascular endothelial growth factor in hematologic malignancies.
@en
P2093
P2860
P356
P1476
Targeting the vascular endothelial growth factor in hematologic malignancies.
@en
P2093
Iris Gehrke
Julian Paesler
Karl-Anton Kreuzer
Simon Jonas Poll-Wolbeck
P2860
P304
P356
10.1111/EJH.12009
P577
2012-09-20T00:00:00Z